Centerstone’s Ketamine/Esketamine Program for Treatment-Resistant Depression featured on news broadcast

Centerstone’s new therapy program for individuals seeking treatment for severe depression was featured recently on WFLA-TV.

Through the program, Centerstone can offer Spravato, a nasal spray that contains the FDA-approved medication Esketamine, and ketamine infusion therapy for people who have been treated for depression with no improvement in symptoms.

To learn more about this program, please go online to centerstone.org/esketamine. To view this video, please click here.

Location Finder

Related Posts

What bipolar disorder is, and what it isn’t

Health & Wellness
Everyone experiences shifts in mood from time to time. These are often brought about by changes in circumstances, stress, ...

depression Mental Health bipolar disorder

Colder Weather and Seasonal Affective Disorder (SAD)

Mental Health
Health & Wellness
This time of year when the weather is cold, wet, and dreary, there are many days when we’d like ...

depression Mental Health

Centerstone Launches New Treatment Therapies for Depression

Press Release
Centerstone, a national leader in behavioral health care, has introduced new therapies for individuals seeking treatment for severe depression. ...

florida depression Treatment

How Can You Cope with a Crisis?

Health & Wellness
Tragedies happen in our world every day, and many of these tragedies can affect us deeply. Beyond a trauma ...

depression grief

Depression Treatment Protocol Pilot for Seniors and Disabled Adults

Health & Wellness
Depression is a very real and disabling condition that affects individuals of all ages and abilities; however, the impact ...

indiana depression

Call Now

photo of
44 Vantage Way
Nashville, TN, 37228 United States